[{"address1": "3060 Pegasus Park Drive", "address2": "Building 6", "city": "Dallas", "state": "TX", "zip": "75247", "country": "United States", "phone": "310 618 6994", "website": "https://www.fortebiorx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A.  Wagner Ph.D.", "age": 53, "title": "CEO, President & Chairman", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 960225, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antony A. Riley CPA", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 568480, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara K. Finck M.D.", "age": 76, "title": "Chief Medical Clinician & Director", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Roenfeldt", "title": "Chief Operating Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven  Ruhl", "age": 66, "title": "Chief Technical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.3, "open": 7.4, "dayLow": 7.2575, "dayHigh": 7.8, "regularMarketPreviousClose": 7.3, "regularMarketOpen": 7.4, "regularMarketDayLow": 7.2575, "regularMarketDayHigh": 7.8, "beta": 1.445, "forwardPE": -0.508, "volume": 17610, "regularMarketVolume": 17610, "averageVolume": 3840, "averageVolume10days": 11220, "averageDailyVolume10Day": 11220, "marketCap": 11126419, "fiftyTwoWeekLow": 7.0, "fiftyTwoWeekHigh": 22.875, "fiftyDayAverage": 11.6911, "twoHundredDayAverage": 15.30515, "currency": "USD", "enterpriseValue": -13838847, "floatShares": 883644, "sharesOutstanding": 1460160, "sharesShort": 933, "sharesShortPriorMonth": 472, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.00059999997, "heldPercentInsiders": 0.108780004, "heldPercentInstitutions": 0.55787, "shortRatio": 0.27, "shortPercentOfFloat": 0.0007, "bookValue": 11.635, "priceToBook": 0.65492046, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -35758000, "trailingEps": -17.25, "forwardEps": -15.0, "lastSplitFactor": "1:15", "lastSplitDate": 1592265600, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "FBRX", "underlyingSymbol": "FBRX", "shortName": "Forte Biosciences, Inc.", "longName": "Forte Biosciences, Inc.", "firstTradeDateEpochUtc": 1492090200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f04f9b0f-d548-36f2-85cf-42c97dc26955", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.62, "targetHighPrice": 150.0, "targetLowPrice": 68.75, "targetMeanPrice": 97.92, "targetMedianPrice": 75.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 24498000, "totalCashPerShare": 16.778, "quickRatio": 2.687, "currentRatio": 2.82, "returnOnAssets": -0.81247, "returnOnEquity": -1.70907, "freeCashflow": -18242876, "operatingCashflow": -30630000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]